National guidance and local pathways answer different clinical questions. Confusing the two — or using AI that obscures the distinction — creates clinical risk that neither source intended.
National Guidance: What Is Recommended?
National guidelines establish the evidence-based framework. NICE guidelines provide comprehensive recommendations grounded in systematic evidence review, cost-effectiveness analysis, and expert consensus. CKS provides primary-care-specific management summaries. BNF provides independently curated prescribing guidance — doses, interactions, contraindications, monitoring. SIGN provides Scottish evidence-based recommendations.
National guidance answers: "What does the evidence say the best approach is?" It provides diagnostic principles, treatment stepladders, monitoring intervals, safety-netting triggers, and referral criteria. But it does not specify how these translate into local operational reality.
Local Pathways: What Happens Here?
Local guidelines translate national recommendations into operational context — answering questions national guidelines structurally cannot.
Referral routes. NICE says "refer urgently." The local pathway specifies to which service, via which route (eRS, letter, phone, specific referral form), with which mandatory information, at which urgency threshold. A GP in Tower Hamlets and a GP in rural Devon follow the same NICE guideline but use entirely different referral mechanisms, receiving services, and turnaround expectations. The NICE guideline is nationally identical. The referral pathway is locally unique.
Local antimicrobial policies. NICE provides national recommendations. Local formularies reflect local resistance patterns — which may differ substantially between regions, between hospitals, and between primary and secondary care. Prescribing the nationally recommended antibiotic when the local policy specifies a different first-line agent may be clinically reasonable but governance-non-compliant and antimicrobial-stewardship-inappropriate.
Imaging access. What a GP can request directly versus what requires secondary care referral varies by Trust, ICB, modality, and clinical indication. National guidance may recommend an MRI that the local system requires a specialist referral to obtain.
Community services. Mental health crisis teams, community rehabilitation, physiotherapy, district nursing, and social care operate with locally defined criteria, hours, geographic boundaries, and referral mechanisms. NICE recommends referral to a service type. The local pathway specifies which service exists locally and how to access it.
Shared care. Drug monitoring shared between primary and secondary care follows locally negotiated protocols. The SmPC says "monitor LFTs every 2 weeks." The local shared-care protocol says "secondary care monitors for the first 3 months, then primary care takes over with monthly LFTs." Both are relevant. Neither alone is sufficient.
When National Guidance Should Lead
Diagnostic principles — the clinical features, investigation thresholds, and diagnostic criteria that define conditions are nationally standardised and evidence-based. A GP in London and a GP in Manchester apply the same NICE diagnostic criteria for the same condition. Broad management frameworks — step-up treatment ladders, treatment targets, and evidence-based management hierarchies. Prescribing safety — contraindications, interactions, pregnancy and breastfeeding safety, dose adjustments in renal and hepatic impairment. Red flags and safety-netting triggers — the warning signs that should prompt urgent assessment or referral, regardless of local service configuration. Evidence-based treatment recommendations — what the evidence supports as the most effective and cost-effective approach for the population.
For these questions, national guidance is the primary reference. Local pathways should not contradict national evidence without clear, documented, and clinically defensible rationale.
When Local Guidance Matters More
Referral routes and thresholds — where to send the patient, via which mechanism, with which mandatory information. A 2-week-wait referral in one ICB may use a different form, different receiving service, and different required investigations than the neighbouring ICB — even though the NICE suspected cancer guideline is nationally identical. Antimicrobial formulary choices — which antibiotic is first-line locally, reflecting local resistance patterns, local stewardship agreements, and local pharmacy availability. Service availability — what community services exist locally and how to access them, including crisis teams, community mental health, rehabilitation services, and social prescribing. Imaging access — whether a GP can request a CT head directly or needs to refer to secondary care, which varies by Trust and modality. Shared care arrangements — locally negotiated protocols for drug monitoring shared between primary and secondary care, including responsibility transfer timings and monitoring intervals.
For these questions, the clinician needs the local implementation detail — not just the national framework.
What Happens When They Differ
Local and national guidelines sometimes diverge for legitimate reasons — local resource constraints, different patient demographics, local resistance patterns, or historical agreements that predate current national guidance.
A practical framework for navigating divergence: identify the question type — is it a clinical management question (national guidance leads) or an operational implementation question (local pathway leads)? Check national guidance for the evidence-based recommendation. Check local pathway for the operational reality. Check the formulary for local prescribing preferences. Document the rationale for whichever approach is followed — especially when the local approach differs from the national recommendation. Escalate genuine uncertainty to a senior colleague, pharmacist, or governance lead rather than guessing which guidance takes priority.
The clinician should not silently follow local guidance that contradicts national evidence without understanding why the divergence exists and documenting the rationale. Equally, the clinician should not ignore local pathways by defaulting to national guidance when the local pathway addresses operational realities that the national guideline does not cover.
Why AI Search Must Show the Source Type
A local answer should not masquerade as national guidance. A national answer should not imply local service availability. Every AI-generated clinical response should show its source type — national guideline, local pathway, formulary, SmPC, peer-reviewed evidence. Without this transparency, the clinician cannot assess applicability.
A tool that says "refer to cardiology" without specifying whether this is a NICE recommendation or a local pathway recommendation has obscured critical context. A tool that recommends an antibiotic without distinguishing between NICE recommendation and local formulary may lead to governance-non-compliant prescribing.
How iatroX Approaches This
iatroX emphasises national guideline sources — NICE, CKS, BNF, SmPC — with visible citations and source hierarchy. Calculators reference the guidelines that recommend them. Exam Q-banks teach the national evidence base. Local pathway context is the next logical layer — but the national evidence must remain visible and distinct.
Ask iatroX for the national clinical answer, then apply local pathways where required →